Kobayashi Pharmaceutical Co., Ltd.
4967
Rang in Aktien
#4483
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries,... Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Aktienkurs
$45.65
Marktkapitalisierung
$3.39B
Veränderung (1 Tag)
-0.40%
Veränderung (1 Jahr)
30.30%
Land
JP
Handel Kobayashi Pharmaceutical Co., Ltd. (4967)
Kategorie
Consumer Defensive
P/S-Verhältnis für Kobayashi Pharmaceutical Co., Ltd. (4967)
P/S-Verhältnis zum October 2026 TTM: 3.17
Laut den neuesten Finanzberichten und dem Aktienkurs von Kobayashi Pharmaceutical Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 3.17. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 2.80.
P/S-Verlauf für Kobayashi Pharmaceutical Co., Ltd. von 2005 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 3.17 | 30.61% |
| 2025 | 2.43 | -12.95% |
| 2024 | 2.80 | -5.80% |
| 2023 | 2.97 | -29.12% |
| 2022 | 4.19 | -7.92% |
| 2021 | 4.55 | -30.53% |
| 2020 | 6.55 | 51.39% |
| 2019 | 4.33 | 22.71% |
| 2018 | 3.53 | -4.20% |
| 2017 | 3.68 | 40.51% |
| 2016 | 2.62 | -4.10% |
| 2015 | 2.73 | 42.68% |
| 2014 | 1.91 | 29.25% |
| 2013 | 1.48 | 14.58% |
| 2012 | 1.29 | 6.86% |
| 2011 | 1.21 | -0.97% |
| 2010 | 1.22 | 15.03% |
| 2009 | 1.06 | 52.50% |
| 2008 | 0.70 | -2.96% |
| 2007 | 0.72 | 2.06% |
| 2006 | 0.70 | 24.74% |
| 2005 | 0.56 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 4.28 | 34.75% |
US
|
|
| 4.52 | 42.49% |
FR
|
|
| 3.54 | 11.47% |
US
|
|
| 6.51 | 105.04% |
IN
|
|
| 2.50 | -21.37% |
US
|
